Log In
BCIQ
Print this Print this
 

Amikacin Fosfomycin Inhalation System

Also known as: Amikacin/fosfomycin inhalation solution

  Manage Alerts
Collapse Summary General Information
Company Cardeas Pharma Corp.
DescriptionInhalation solution of the antibiotics amikacin and fosfomycin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPneumonia
Indication DetailsTreat Gram-negative pneumonia in mechanically ventilated patients; Treat hospital-acquired/ventilator-associated pneumonia
Regulatory Designation U.S. - Fast Track (Treat Gram-negative pneumonia in mechanically ventilated patients);
U.S. - Qualified Infectious Disease Program (Treat Gram-negative pneumonia in mechanically ventilated patients)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today